PHILHAVEN
1. Target Overview & Investment Thesis
PHILHAVEN is a 118-bed community hospital in LEBANON, PA with $73.1M in net patient revenue and a -32.1% operating margin. The hospital serves a payer mix of 2.2% Medicare, 0.0% Medicaid, and 97.8% commercial.
Thesis: Undervalued. Our ML models identify $5.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -32.1% to -24.7% (+736bps).
| Net Revenue HCRIS | $73.1M |
| Current EBITDA COMPUTED | $-23.4M |
| Operating Margin COMPUTED | -32.1% |
| Occupancy HCRIS | 96.8% |
| Revenue / Bed COMPUTED | $619K |
| Net-to-Gross HCRIS | 59.8% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -32.1% places it below the state median. Among 103 size-comparable peers (59-236 beds), the median margin is -5.8%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (59-236), prioritizing same-state peers. 103 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| PHILHAVEN (Target) | PA | 118 | $73.1M | -32.1% |
| WILLIAMSPORT HOSPITAL & MEDICA | PA | 227 | $459.8M | -8.4% |
| THE CHAMBERSBURG HOSPITAL | PA | 234 | $435.1M | 5.2% |
| ST LUKE HOSPITAL ANDERSON CAMP | PA | 193 | $433.0M | 20.6% |
| THE GETTYSBURG HOSPITAL | PA | 76 | $341.8M | 18.4% |
| ST. JOSEPH MEDICAL CENTER | PA | 132 | $334.8M | 13.2% |
| FORBES REGIONAL HOSPITAL | PA | 233 | $327.4M | -3.8% |
| HOLY SPIRIT HOSPITAL | PA | 231 | $295.1M | -1.0% |
| EPHRATA COMMUNITY HOSPITAL | PA | 115 | $291.8M | 3.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.5M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $889K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $47K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-23.4M |
| + RCM Uplift | +$5.4M |
| Pro Forma EBITDA | $-18.1M |
| Current Margin | -32.1% |
| Pro Forma Margin | -24.7% |
| WC Released (1x) | $2.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-36.1M | $-100.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-36.1M | $-122.6M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-32.5M | $-116.6M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-32.5M | $-136.7M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-39.7M | $-116.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-39.7M | $-140.5M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 103 hospitals with 59-236 beds
- Same-state prioritization (n=104)
- Comp margins: P25=-18.4% / P50=-5.8% / P75=7.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.